Pomalidomide-PEG1-CO2H
CAS No. 2139348-60-8
Pomalidomide-PEG1-CO2H( Pomalidomide-PEG1-C2-COOH )
Catalog No. M28266 CAS No. 2139348-60-8
Pomalidomide-PEG1-CO2H is a synthetic E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a 2-unit PEG linker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 37 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 116 | In Stock |
|
| 50MG | 160 | In Stock |
|
| 100MG | 237 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 584 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePomalidomide-PEG1-CO2H
-
NoteResearch use only, not for human use.
-
Brief DescriptionPomalidomide-PEG1-CO2H is a synthetic E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a 2-unit PEG linker.
-
DescriptionPomalidomide-PEG1-CO2H is a synthetic E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a 2-unit PEG linker.(In Vitro):PROTACs contain two distinct ligands, one for the E3 ubiquitin ligase and the other for the target protein, linked by a linker.
-
In Vitro——
-
In Vivo——
-
SynonymsPomalidomide-PEG1-C2-COOH
-
PathwayOthers
-
TargetOther Targets
-
RecptorHBV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2139348-60-8
-
Formula Weight389.36
-
Molecular FormulaC18H19N3O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (321.04 mM)
-
SMILESO=C(O)CCOCCNC1=CC=CC=2C(=O)N(C(=O)C12)C3C(=O)NC(=O)CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Tibesaikosaponin V
Tibesaikosaponin V (TKV) is a triterpene diglycoside, which can be isolated from the methanol extract of the roots of Bupleurum chinense DC.. Tibesaikosaponin V inhibits lipid accumulation and triacylglycerol content occurred without cytotoxicity to adipocytes. Tibesaikosaponin V suppresses the mRNA expression of nuclear transcription factors, such as peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα). Tibesaikosaponin V inhibits 3T3-L1 preadipocyte differentiation. Tibesaikosaponin V can be used fro research of obesity and its associated metabolic disorders.
-
[Phe2, Nle4]-ACTH (1...
[Phe2, Nle4]-ACTH (1-24)
-
PTGR2-IN-22
PTGR2-IN-22 is a potent inhibito of PTGR2r(IC50 : 0.7 μM). It increases 15-keto-PGE2-dependent PPARγ transcriptional activity in PTGR2-transfected HEK293T cells.
Cart
sales@molnova.com